Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry for v3.5.4 was added to the Record History, replacing the previous v3.5.3 in the history log.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page version/revision label was updated from **v3.5.2** to **v3.5.3**, indicating a minor interface or system update without changing the study record content.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision v3.5.2 has been added and the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check70 days agoChange DetectedA new record version v3.5.0 was added and the previous version v3.4.3 was removed from the history.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.3 was added to the history, replacing the previous v3.4.2 entry in the record history.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded Revision: v3.4.2 banner on the page. Removed notices about government funding/operating status and the previous v3.4.1 revision.SummaryDifference0.7%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.